Pregnancy-Induced Sweet's Syndrome Treated with Infliximab
Conclusion: The "off -label" use of infliximab is beneficial for relapsing and resistant Sweet's syndrome.
Source: Medical Principles and Practice - Category: Internal Medicine Source Type: research
More News: Corticosteroid Therapy | Dermatology | Endoscopy | Internal Medicine | Pregnancy | Remicade | Skin | Skin Biopsy